Evidence map›Paper›PMID 36619223›Full record

ArticleInternational journal of medical sciences2023

Inflammation as an exacerbation marker and target for prophylaxis against Coronavirus Disease 2019-related thrombosis.

Daisuke Ono, Yuko Ohno, Yoshihiko Izumida, Hideaki Ohno, Hideaki Oka, Kyosuke Takeshita

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daisuke OnoDepartment of Infectious Diseases and Infection Control, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Yuko OhnoDepartment of Clinical Laboratory, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Yoshihiko IzumidaDepartment of Endocrinology and Diabetes, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Hideaki OhnoDepartment of Infectious Diseases and Infection Control, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Hideaki OkaDepartment of General Internal Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Kyosuke TakeshitaDepartment of Clinical Laboratory, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Saitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19ThrombosisHumansImmunosuppressive AgentsInflammationLactate DehydrogenasesMaleMiddle AgedOxygenPlasminogen Activator Inhibitor 1Immunosuppressive AgentsLactate DehydrogenasesOxygenPlasminogen Activator Inhibitor 1COVID-19Immunosuppressantsinflammationliver transplantSARS-CoV-2thrombosis

Identifiers

PMID36619223
PMCPMC9812812
OpenAlexW4313579642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.